T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Dave & Buster's
PLAY
$370M
| $595K | ﹤0.01% |
36,688
+8,138
| +29% | +$136K |
|
2302
Kodak
KODK
$978M
| $593K | ﹤0.01% |
70,021
-7,151
| -9% | -$53.5K |
|
2303
Patria Investments
PAX
$1.88B
| $592K | ﹤0.01% |
37,215
+2,495
| +7% | +$37.3K |
|
2304
National Presto Industries
NPK
$987M
| $590K | ﹤0.01% |
5,526
+355
| +7% | +$37.2K |
|
2305
Trip.com Group
TCOM
$28.3B
| $590K | ﹤0.01% |
8,188
-1,812
| -18% | -$130K |
|
2306
Fulgent Genetics
FLGT
$513M
| $589K | ﹤0.01% |
22,413
+1,521
| +7% | +$39.5K |
|
2307
Marten Transport
MRTN
$1.24B
| $589K | ﹤0.01% |
51,716
+10,073
| +24% | +$107K |
|
2308
GigaCloud Technology
GCT
$1.9B
| $585K | ﹤0.01% |
14,880
+984
| +7% | +$32.5K |
|
2309
HealthStream
HSTM
$849M
| $584K | ﹤0.01% |
25,297
+3,067
| +14% | +$77.1K |
|
|
DENN
2310
DELISTED
Denny's
DENN
| $580K | ﹤0.01% |
93,170
+5,327
| +6% | +$30.2K |
|
2311
Franklin Covey
FC
$227M
| $580K | ﹤0.01% |
34,518
+11,700
| +51% | +$196K |
|
2312
Manitowoc
MTW
$753M
| $578K | ﹤0.01% |
48,179
+2,741
| +6% | +$31.2K |
|
2313
Camping World
CWH
$675M
| $577K | ﹤0.01% |
59,216
+2,630
| +5% | +$32.6K |
|
|
BLSH
2314
Bullish
BLSH
$4.17B
| $575K | ﹤0.01% |
+15,179
| New | +$739K |
|
2315
Movado Group
MOV
$796M
| $572K | ﹤0.01% |
27,728
| – | – |
|
2316
AMC Entertainment Holdings
AMC
$2.35B
| $570K | ﹤0.01% |
365,291
+44,518
| +14% | +$106K |
|
2317
AngioDynamics
ANGO
$647M
| $569K | ﹤0.01% |
44,298
+2,263
| +5% | +$27.9K |
|
2318
Heartland Express
HTLD
$979M
| $569K | ﹤0.01% |
63,009
+22,417
| +55% | +$187K |
|
2319
Koppers
KOP
$874M
| $569K | ﹤0.01% |
20,980
+186
| +0.9% | +$5.2K |
|
2320
Caleres
CAL
$461M
| $568K | ﹤0.01% |
46,613
+8,927
| +24% | +$110K |
|
2321
Evolus
EOLS
$530M
| $568K | ﹤0.01% |
85,364
+22,029
| +35% | +$149K |
|
2322
Red Cat Holdings
RCAT
$1.56B
| $565K | ﹤0.01% |
71,177
-1,028,279
| -94% | -$9.84M |
|
|
ACR
2323
ACRES Commercial Realty
ACR
$101M
| $563K | ﹤0.01% |
26,351
| – | – |
|
2324
Gevo
GEVO
$401M
| $562K | ﹤0.01% |
280,772
-82,566
| -23% | -$182K |
|
|
HPP
2325
Hudson Pacific Properties
HPP
$787M
| $562K | ﹤0.01% |
51,833
+13,326
| +35% | +$198K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.